|
Critical Path to Tuberculosis (TB) Drug Regimens (CPTR) Rapid Drug Sensitivity Testing (DST) Consortium
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
The purpose of the Critical Path to Tuberculosis (TB) Drug Regimens (CPTR) Rapid Drug Sensitivity Testing (DST) Consortium is to support and sustain discussion, share information, and to coordinate clinical trials of new TB drug combinations. The overall goal is to rapidly advance new cost-effective therapies while maintaining the highest standards of scientific rigor. The Consortium will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations.
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
DailyMed provides high quality information about marketed drugs, including FDA labels (package inserts). The Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed as a public service, free of advertising.
|
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
NIA developed a Memorandum of Understanding (MoU) to assist grantees with accessing Centers for Medicare & Medicaid Services (CMS) data. It is anticipated that this initiative will create a more user friendly and more cost efficient means for grantees to access CMS data especially the need to access Part D data. Specifically, this MOU gives CMS''s Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. This includes activities for remote access data enclave.
|
|
Demand Reduction Interagency Working Groups
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation.
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, NHLBI
|
Oversees DoD research in resuscitation and transfusion.
|
|
Developing Clinical Vocabulary Standards for Public Health Reporting
|
Resource Development
|
CDC
|
NLM
|
This collaboration between NLM and CDC is to develop Logical Observation Identifiers Names and Codes (LOINC) codes for use in public health reporting, including tumor registry reporting, and reportable disease reporting.
|
|
Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission
|
Research Initiative
|
FDA
|
NIAID
|
NIH has been working with the FDA toward development and use of a non-human primate model of pertussis disease and transmission.
|
|
DHHS Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee is charged with developing strategies to improve the fraction of healthcare professionals who are vaccinated with the influenza vaccine.
|
|
DHHS Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee serves as the major policy advisory committee in the nation for healthcare epidemiology.
|
|
DHHS Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections.
|